Connect with us

Technology

Fusion Biopsy Market is expected to generate a revenue of USD 1448.15 Million by 2032, Globally, at 8.9% CAGR: Verified Market Research®

Published

on

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the Fusion Biopsy Market. This in-depth study provides industry leaders, medical device manufacturers, healthcare providers, and investors with critical insights into the evolving landscape of fusion biopsy technologies.

LEWES, Del., March 5, 2025 /PRNewswire/ — The Global Fusion Biopsy Market Size is projected to grow at a CAGR of 8.9% from 2025 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 732.13 Million in 2024 and is expected to reach USD 1448.15 Million by the end of the forecast period.

The Fusion Biopsy Market is witnessing rapid growth, driven by increasing adoption of precision diagnostic techniques for prostate cancer and other malignancies. Fusion biopsy, which combines MRI and ultrasound imaging, has emerged as a game-changer in early cancer detection and treatment planning. The report delves into market dynamics, including technological advancements, regulatory updates, and competitive strategies shaping the industry.

Key Highlights of the Market Report:

Market Size & Growth Projections – Detailed analysis of the current market valuation, CAGR, and forecasted growth potential through 2032.Technological Innovations – Insights into the latest advancements in MRI-ultrasound fusion biopsy techniques, AI-powered imaging, and real-time navigation systems.Competitive Landscape – Profiles of key players, including mergers, acquisitions, and strategic partnerships that are redefining the market.Regional Analysis – Market trends and investment opportunities across North America, Europe, Asia-Pacific, and other emerging regions.End-User Insights – Adoption trends across hospitals, diagnostic centers, and research institutions.

Why This Report Matters?

With the increasing burden of cancer cases worldwide, precision diagnostics are more crucial than ever. Industry stakeholders seeking data-driven insights on investment opportunities, emerging technologies, and strategic positioning will find this report invaluable.

For more information or to purchase the report, please contact us at: https://www.verifiedmarketresearch.com/download-sample?rid=480739

Browse in-depth TOC on “Global Fusion Biopsy Market Size

202 – Pages
126 – Tables
37 – Figures

Report Scope

REPORT ATTRIBUTES

DETAILS

STUDY PERIOD

2021-2032

BASE YEAR

2024

FORECAST PERIOD

2025-2032

HISTORICAL PERIOD

2021-2023

UNIT

Value (USD Million)

KEY COMPANIES PROFILED

Eigen, Koninklijke Philips N.V., Hitachi Ltd., Focal Healthcare, MedCom, ESAOTE SPA, KOELIS, BK Medical Holding Company Inc., Biobot Surgical Pte Ltd, Exact Imaging, and UC-Care Medical Systems Ltd.

SEGMENTS COVERED

Biopsy Route, Product, End User, And Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Global Fusion Biopsy Market Overview

Key Market Drivers

Rising Prevalence of Prostate Cancer and Need for Early Diagnosis: The rising global prevalence of prostate cancer significantly propels the Fusion Biopsy Market. Conventional biopsy techniques frequently result in false negatives, postponing essential therapies. Fusion biopsy, integrating MRI and ultrasound, improves precision and early diagnosis, establishing it as the preferred method for urologists and oncologists. As healthcare providers emphasize precision diagnostics, the need for fusion biopsy systems is anticipated to increase, propelling market expansion.

Technological Advancements in Imaging and AI Integration: The advancement of MRI-ultrasound fusion biopsy technology, enhanced by artificial intelligence and real-time imaging, is revolutionizing cancer diagnoses. AI-driven automation enhances lesion diagnosis and biopsy targeting, minimizing mistakes and increasing productivity. The Fusion Biopsy Market is experiencing swift adoption in hospitals and diagnostic centers as manufacturers invest in advanced imaging systems. Organizations utilizing AI-driven biopsy advancements will acquire a significant competitive advantage.

Increasing Investments and Favorable Regulatory Approvals: Government entities and private investors are significantly financing precision diagnostic solutions, hence generating development prospects in the Fusion Biopsy Market. Beneficial FDA approvals and efficient regulatory frameworks are accelerating product introductions and promoting innovation. Increasing healthcare expenditures and reimbursement policies favoring sophisticated biopsy treatments are enhancing market penetration. Enterprises that use regulatory changes will experience substantial revenue growth.

To Purchase a Comprehensive Report Analysis: https://www.verifiedmarketresearch.com/select-licence?rid=480739

Market Restraints Hindering the Market Growth

High Cost of Fusion Biopsy Systems and Procedures: Notwithstanding its clinical benefits, the Fusion Biopsy Market encounters obstacles owing to the substantial expense of MRI-ultrasound fusion biopsy devices. Advanced imaging technology and AI-driven biopsy instruments necessitate significant investment, constraining adoption by small and medium-sized healthcare institutions. Cost-sensitive markets, especially in emerging areas, face challenges with affordability, hindering widespread implementation and impeding market growth.

Limited Access to Skilled Radiologists and Urologists: The efficacy of fusion biopsy is contingent upon the proficiency of radiologists and urologists skilled in MRI-ultrasound-guided techniques. A deficiency of trained professionals, particularly in emerging regions, is constraining market expansion. Healthcare facilities encounter difficulties in adopting and optimizing fusion biopsy technologies without enough training. Mitigating this deficiency through educational and certification initiatives is essential for fostering enduring adoption and maintaining growth in the Fusion Biopsy Market.

Stringent Regulatory Requirements and Approval Delays: Despite the rise in regulatory approvals, rigorous compliance mandates and protracted approval procedures present obstacles for new market entrants. The Fusion Biopsy Market has intricate clinical validation procedures, hindering product commercialization. Companies must manage changing rules, which can impede innovation and delay market entry. Organizations that strategically adhere to compliance requirements will be more equipped to navigate these challenges and foster continuous growth.

Geographical Dominance:

North America Leads the Fusion Biopsy Market with Advanced Healthcare Infrastructure

North America leads the Fusion Biopsy Market, propelled by advanced healthcare infrastructure, widespread acceptance of precision diagnostics, and increasing incidences of prostate cancer. The United States excels in robust research and development spending and advantageous reimbursement policies, facilitating industry growth. This supremacy draws international entities, promoting innovation and technical progress. As demand escalates, enterprises focusing on North America have a competitive advantage in revenue expansion.

Key Players

The “Global Fusion Biopsy Market” study report will provide a valuable insight with an emphasis on the global market.  The major players in the market are Eigen, Koninklijke Philips N.V., Hitachi Ltd., Focal Healthcare, MedCom, ESAOTE SPA, KOELIS, BK Medical Holding Company Inc., Biobot Surgical Pte Ltd, Exact Imaging, and UC-Care Medical Systems Ltd.

Fusion Biopsy Market Segment Analysis

Based on the research, Verified Market Research has segmented the market into Biopsy Route, Product, End User, and Geography.

Fusion Biopsy Market, by Biopsy RouteTransrectalTransperinealFusion Biopsy Market, by ProductEquipmentConsumablesFusion Biopsy Market, by End-UserHospitalsDiagnostic CentersAmbulatory Care CentersAcademic & Research LaboratoriesFusion Biopsy Market, by GeographyNorth AmericaU.SCanadaMexicoEuropeGermanyFranceU.KRest of EuropeAsia PacificChinaJapanIndiaRest of Asia PacificROWMiddle East & AfricaLatin America

Browse Related Reports:

Global Liquid Biopsy Market Size By Biomarker (Circulating Tumor Cells, Circulating Nucleic Acids), By Technology (NGS, PCR Microarrays), By Application (Cancer, Reproductive Health), End-User (Hospitals, Specialty Clinics), By Geography, And Forecast

Global Biopsy Devices Market Size By Product (Instruments For Needle-Based Biopsy, Biopsy Guidance Systems, Biopsy Needles (Disposable, Reusable), Biopsy Forceps), By End User (Hospitals & Clinics, Diagnostic Imaging Centres, Research Labs & Pharmaceutical Companies), By Application (Breast Biopsy, Bone Marrow Biopsy, Colorectal Biopsy, Lung Biopsies, Prostate Biopsies), By Geography, And Forecast

Global Plastic Surgery And Integumentary System Procedures Market Size By Procedure (Prefilled Syringe Biopsy, Excisional Biopsy), By Operating Area (Eyelids, Subcutaneous Tissue), By Application (Skin Grafts, Allograft), By End User (Hospitals And Clinics, Research Laboratories), By Geography, And Forecast

Global Biopsy Needles Market Size By Product Type (Biopsy Needles, Aspiration Needles), By Application (Tumor/Cancer Applications, Wound Applications), By Procedure (Image-guided Procedures, Non-image-guided Procedures), By End-User (Hospitals & Surgical Centers, Diagnostic Clinics & Pathology Laboratories, Ambulatory Care Centers, Research & Academic Institutes), By Geography, And Forecast

Top 7 Implantable Medical Device Companies advancing patient care

Visualize Fusion Biopsy Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.

With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.

VMR’s domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.

Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR’s dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter | Threads | Instagram | Facebook

Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fusion-biopsy-market-is-expected-to-generate-a-revenue-of-usd-1448-15-million-by-2032–globally-at-8-9-cagr-verified-market-research-302393044.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

The Inner Circle acknowledges Russell E. Jones as a Pinnacle Professional Member

Published

on

By

CHANDLER, Ariz., July 21, 2026 /PRNewswire/ — Prominently featured in The Inner Circle, Russell E. Jones is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for his contributions to Pioneering Innovation in Software Engineering and Communications.

With over three decades of experience in software engineering and software quality engineering, Russell E. Jones continues to lead transformative innovations in the field of communications as the Executive Director of Integration, Verification, and Validation at Iridium Communications Inc.. Since stepping into this role in 2021, Mr. Jones has overseen critical processes that ensure the seamless integration and functionality of the company’s sophisticated communication systems.

His promotion to this key leadership position followed a successful tenure as Director of SV Software Engineering at Iridium, where his leadership was pivotal in advancing the company’s technological capabilities. Before joining Iridium, Mr. Jones gained extensive experience in systems engineering and software testing through impactful roles at Motorola and Boeing, further solidifying his reputation as an innovator in the field.

Mr. Jones’s academic foundation includes an Associate of Arts in Electronics Technology (1990) and a Bachelor of Science in Technical Management (2001), both from DeVry University. These credentials have been instrumental in shaping his career, which has spanned satellite testing, systems engineering, and software integration.

Throughout his journey, Mr. Jones credits his family’s unwavering love and support and his mother and father’s influence for instilling the values of hard work and resourcefulness—traits that have been the cornerstone of his success.

Looking to the future, Mr. Jones is passionate about educating the next generation of engineers. His vision includes addressing educational gaps by teaching courses, presenting at conferences, and advocating for the inclusion of testing and integration in academic curricula. His goal is to inspire future leaders while continuing to contribute to the advancement of technology at Iridium.

Contact: Katherine Green, 516-825-5634, editorialteam@continentalwhoswho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-russell-e-jones-as-a-pinnacle-professional-member-302831135.html

SOURCE The Inner Circle

Continue Reading

Technology

Vision Marine Technologies Announces Next Phase of Its Marine Technology Strategy

Published

on

By

Company plans to leverage its integrated operating platform to support technology development, commercialization and long-term growth.

BOISBRIAND, QC, July 21, 2026 /PRNewswire/ — Vision Marine Technologies Inc. (NASDAQ: VMAR; TSXV: VMAR) (“Vision Marine” or the “Company”), a marine technology company combining proprietary high-voltage electric propulsion technology with an integrated marine retail, marina and service platform through Nautical Ventures, today announced the next phase of its long-term strategy to advance and commercialize marine technologies through its operating platform.

The initiative establishes a framework through which Vision Marine intends to pursue internal development, technology partnerships and selected strategic opportunities, which may include mergers or acquisitions, that complement its existing capabilities and relate to the recreational boating industry.

The initiative builds upon the strategy presented by Vision Marine in May 2026: connecting proprietary marine technology with direct retail distribution, vessel integration capabilities, marina infrastructure, service operations and established customer relationships.

Over the past year, Vision Marine has integrated and expanded the Nautical Ventures platform, commercially launched and begun customer deliveries of its E-Motion™ 180 high-voltage electric propulsion system, expanded its intellectual property portfolio, continued optimizing its real estate and operating structure, and completed its previously announced at-the-market equity offering program. As previously disclosed, the Company currently has no active ATM program.

As previously disclosed, net cash provided by operating activities totaled approximately US$2.4 million for the nine-month period ended May 31, 2026. This result was supported by working-capital management, including the reduction and monetization of inventory. Management believes this reflects its focus on operational discipline and capital efficiency. Net cash provided by operating activities is distinct from net income and should not be interpreted as profitability.

The Company intends to use its existing customer relationships, distribution channels and service infrastructure to evaluate and, where appropriate, commercialize complementary marine technologies.

By combining technology development and vessel integration with retail distribution, marina operations, service, rentals and direct customer engagement, Vision Marine intends to evaluate whether new technologies can be introduced and supported through its existing operations. Any such initiatives will remain subject to customer demand, technical development and integration requirements, operating costs, financing availability, market conditions, regulatory approvals and disciplined capital allocation. There can be no assurance that these initiatives will result in commercialization, additional revenue or anticipated financial benefits.

“We are not beginning from a concept. We are expanding from a platform that is already in operation,” said Alexandre Mongeon, Chief Executive Officer of Vision Marine. “Vision Marine now connects proprietary technology with vessel integration, retail distribution, marina infrastructure, service capabilities and direct customer access. Our objective is to use these capabilities to evaluate and, where appropriate, support the development and commercialization of complementary marine technologies.”

“Proprietary electric propulsion remains central to Vision Marine’s technology strategy,” continued Mongeon. “We intend to evaluate complementary technologies that could improve vessel integration, energy management, connectivity, serviceability and the overall ownership experience. Our objective is to strengthen our marine technology platform through internal development, strategic partnerships and carefully selected strategic opportunities, while maintaining disciplined capital allocation.”

Vision Marine intends to prioritize initiatives that it believes complement its existing platform and may provide commercial value. In evaluating potential opportunities, the Company will consider expected costs, technical and operational requirements, financing needs, integration risks and potential financial benefits. There can be no assurance that any initiative will expand recurring revenue, improve margins or strengthen cash generation.

This announcement does not constitute the announcement of any acquisition, merger or definitive transaction. There can be no assurance that any evaluation or discussion will result in a completed transaction. Any material transaction will be disclosed in accordance with applicable securities laws and the requirements of Nasdaq and the TSX Venture Exchange.

About Vision Marine Technologies Inc.

Vision Marine Technologies Inc. (NASDAQ: VMAR; TSXV: VMAR) is a marine technology company specializing in high-voltage electric propulsion systems and recreational boating solutions. Its E-Motion™ electric powertrain technology is designed to provide a marine-specific, integration-ready propulsion solution for boat manufacturers. Through Nautical Ventures, Vision Marine also operates an integrated marine retail, marina, service and rental platform supporting both electric and internal-combustion recreational boating. For more information, visit visionmarinetechnologies.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable Canadian securities laws and the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, without limitation, statements regarding Vision Marine’s business strategy; the advancement and commercialization of marine technologies; internal development initiatives; potential technology partnerships, investments, mergers, acquisitions and other strategic opportunities; the anticipated use and potential benefits of the Company’s operating platform; the introduction and commercialization of complementary technologies; the potential expansion of recurring revenue; potential improvements in margins and cash generation; and the Company’s capital allocation priorities and long-term growth objectives.

Forward-looking statements can often be identified by words such as “expects,” “plans,” “believes,” “intends,” “anticipates,” “continues,” “estimates,” “projects,” “potential,” “opportunity,” “may,” “could,” “would,” “will” and similar expressions or variations of such words and phrases.

These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These factors include, without limitation, the Company’s ability to execute its business strategy; identify, negotiate, finance, complete and integrate potential strategic transactions; develop and commercialize new technologies; generate market acceptance for its products and services; improve operating performance and achieve profitability; manage liquidity, inventory and floor-plan financing requirements; realize anticipated benefits from the integration of Nautical Ventures; maintain relationships with manufacturers, suppliers and commercial partners; protect its intellectual property; comply with applicable regulatory and listing requirements; and respond to competition, economic conditions, capital-market volatility, supply-chain disruptions and changes affecting the recreational marine industry.

Additional risks and uncertainties are described in the Company’s Annual Report on Form 20-F, as amended, for the year ended August 31, 2025, and in its subsequent filings with the U.S. Securities and Exchange Commission and on SEDAR+. Readers should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Vision Marine undertakes no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/vision-marine-technologies-announces-next-phase-of-its-marine-technology-strategy-302831148.html

SOURCE Vision Marine Technologies, Inc

Continue Reading

Technology

World-Renowned MAGURA USV Manufacturer UFORCE Partners with RECONCRAFT to Build Combat-Tested Autonomous Maritime Drones in the U.S.

Published

on

By

MAGURA family of drones, made exclusively by UFORCE, holds one of the most impactful and reliable combat records in modern maritime warfare, helping drive the Russian Navy from the Black Sea

LONDON and KYIV, Ukraine and WASHINGTON, July 21, 2026 /PRNewswire/ — UFORCE, the Ukraine-origin, UK-based autonomous systems defense technology company built to unify and scale the world’s most combat-proven unmanned platforms, today announced the signing of a memorandum of understanding (MoU) with leading Special Operations combatant craft manufacturer RECONCRAFT, following a ceremony hosted by the Embassy of Ukraine in the United States.

UFORCE USA and RECONCRAFT are partnering to build the world’s most capable autonomous surface vessels as part of the Arsenal of Freedom. UFORCE has also entered the U.S. Drone Dominance competition and related programs in partnership with RECONCRAFT.

The initiative will be led by Sean Plankey, CEO of UFORCE USA. Plankey most recently served as Senior Advisor to the Secretary of Homeland Security, overseeing the United States Coast Guard, and was twice nominated by the President of the United States to lead the Cybersecurity and Infrastructure Security Agency.

Through the partnership, UFORCE will work to make available to the United States its combat-proven full-stack aerial, maritime, and ground unmanned systems, advanced autonomy software, and command-and-control technologies.

The company’s MAGURA family of autonomous surface vessels holds one of the most impactful and reliable combat records in modern maritime warfare and contributed to the destruction of more than a dozen Russian warships in the Black Sea. UFORCE’s portfolio also includes the first autonomous surface vessel to successfully down manned helicopters and fighter aircraft in combat.

“Today’s combat environments show that autonomous warfighting capabilities are a must-have. UFORCE is exceptionally positioned to deliver capabilities already tested by some of the world’s most sophisticated militaries under the most demanding battlefield conditions,” said Oleg Rogynskyy, CEO of UFORCE. “Through this partnership with RECONCRAFT, these combat-proven capabilities will become available to the U.S., combining Ukrainian battlefield innovation with American manufacturing excellence.”

“This partnership demonstrates what’s possible when American manufacturing and combat-proven innovation come together,” said Sean Plankey, CEO of UFORCE USA. “Working with RECONCRAFT, we will help ensure these proven autonomous capabilities become available to the U.S. It’s exactly the kind of industrial partnership the Arsenal of Democracy is designed to enable.”

“RECONCRAFT is building multiple combatant craft platforms trusted by U.S. and Partner Special Operations Forces in the world’s most demanding environments,” said Joe Silkowski, Co-Founder of RECONCRAFT. “Partnering with UFORCE combines our manufacturing expertise and capabilities with the combat-proven autonomy of the MAGURA platform, allowing us to deliver greater capability to American warfighters faster than developing a new system from the ground up.”

About UFORCE

UFORCE USA is a U.S. based, wholly owned subsidiary of Ukrainian-origin defense technology operating company UFORCE, built to unify and scale the world’s most battle-proven autonomous systems. UFORCE unified nine leading Ukrainian defense technology developers and manufacturers into a single company, with registered in London and operations in Ukraine. By combining Ukrainian frontline innovation with Western capital, governance, and global distribution, UFORCE delivers next-generation autonomous defense capabilities to allied militaries. The company’s full-stack platform includes hardware systems spanning aerial, maritime and ground unmanned platforms, advanced autonomy software, and command-and-control solutions.

Media Contact: KekstCNC-UFORCE@kekstcnc.com

About RECONCRAFT

RECONCRAFT is the leading designer and manufacturer of combatant craft for U.S. and Foreign Partner forces.  RECONCRAFT’s global headquarters and primary manufacturing campus is located in the Portland, Oregon, area where the skilled team produces highly sophisticated vessels, manned and unmanned, between multiple Programs of Record.

View original content to download multimedia:https://www.prnewswire.com/news-releases/world-renowned-magura-usv-manufacturer-uforce-partners-with-reconcraft-to-build-combat-tested-autonomous-maritime-drones-in-the-us-302831197.html

SOURCE UFORCE

Continue Reading

Trending